Evolution of Cancer Care in Response to the COVID-19 Pandemic

Eric A Coomes¹, Humaid O Al-Shamsi², Brandon M Meyers³, Waleed Alhazzani⁴, Ahmad Alhuraiji⁵, Roy F Chemaly⁶, Meshari Almuhanna⁷, Robert A Wolff⁸, Nuhad K Ibrahim⁹, Melvin L K Chua¹⁰, Sebastien J Hotte³, Tarek Elfiki¹¹, Giuseppe Curigliano¹², Cathy Eng¹³, Axel Grothey¹⁴, Conghua Xie¹⁵

Affiliations

¹ Division of Infectious Disease, Department of Medicine, University of Toronto, Toronto, Canada.
² Medical Oncology Department, Alzahra Hospital Dubai, Dubai, United Arab Emirates; Department of Medicine, University of Sharjah, Sharjah, United Arab Emirates; Emirates Oncology Society, Dubai, United Arab Emirates.
³ Department of Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, Canada.
⁴ Department of Health Research Methods, Evidence, and Impact and Department of Medicine, McMaster University, Hamilton, Canada.
⁵ Department of Hematology, Kuwait Cancer Control Center, Kuwait City, Kuwait.
⁶ Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
⁷ Min-Sheng General Hospital, Taoyuan District, Taoyuan City, Taiwan.
⁸ Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
⁹ Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
¹⁰ Divisions of Radiation Oncology and Medical Sciences, National Cancer Center Singapore, Singapore; Oncology Academic Program, Duke-National University of Singapore Medical School, Singapore; Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China.
¹¹ Windsor Regional Cancer Center, Windsor, Canada; Department of Oncology, Schulich School of Medicine, University of Western Ontario, London, Canada.
¹² Department of Oncology and Hemato-Oncology and Division of Early Drug Development for Innovative Therapy, University of Milan, Milan, Italy; European Institute of Oncology, IRCCS, and University of Milano, Milan, Italy.
¹³ Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA.
¹⁴ West Cancer Center, University of Tennessee, Memphis, Tennessee, USA.
¹⁵ Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China.

PMID: 32536024
PMCID: PMC7323244
DOI: 10.1634/theoncologist.2020-0451

Comment

Evolution of Cancer Care in Response to the COVID-19 Pandemic

Eric A Coomes et al. Oncologist. 2020 Sep.

. 2020 Sep;25(9):e1426-e1427.

doi: 10.1634/theoncologist.2020-0451. Epub 2020 Jul 7.

Authors

Affiliations

¹ Division of Infectious Disease, Department of Medicine, University of Toronto, Toronto, Canada.
² Medical Oncology Department, Alzahra Hospital Dubai, Dubai, United Arab Emirates; Department of Medicine, University of Sharjah, Sharjah, United Arab Emirates; Emirates Oncology Society, Dubai, United Arab Emirates.
³ Department of Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, Canada.
⁴ Department of Health Research Methods, Evidence, and Impact and Department of Medicine, McMaster University, Hamilton, Canada.
⁵ Department of Hematology, Kuwait Cancer Control Center, Kuwait City, Kuwait.
⁶ Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
⁷ Min-Sheng General Hospital, Taoyuan District, Taoyuan City, Taiwan.
⁸ Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
⁹ Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
¹⁰ Divisions of Radiation Oncology and Medical Sciences, National Cancer Center Singapore, Singapore; Oncology Academic Program, Duke-National University of Singapore Medical School, Singapore; Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China.
¹¹ Windsor Regional Cancer Center, Windsor, Canada; Department of Oncology, Schulich School of Medicine, University of Western Ontario, London, Canada.
¹² Department of Oncology and Hemato-Oncology and Division of Early Drug Development for Innovative Therapy, University of Milan, Milan, Italy; European Institute of Oncology, IRCCS, and University of Milano, Milan, Italy.
¹³ Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA.
¹⁴ West Cancer Center, University of Tennessee, Memphis, Tennessee, USA.
¹⁵ Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China.

PMID: 32536024
PMCID: PMC7323244
DOI: 10.1634/theoncologist.2020-0451

Abstract

In this study, whole exome sequencing was conducted on tumor samples and paired germline samples from patients with Sertoli‐Leydig cell tumors to explore not only DICER1 mutations for Chinese populations but also other genetic variations related to pathogenesis and prognosis, which could lay a preliminary foundation for genetic counseling.

PubMed Disclaimer

Comment on

Beware of the second wave of COVID-19.
Xu S, Li Y. Xu S, et al. Lancet. 2020 Apr 25;395(10233):1321-1322. doi: 10.1016/S0140-6736(20)30845-X. Epub 2020 Apr 8. Lancet. 2020. PMID: 32277876 Free PMC article. No abstract available.

References

1. Souadka A, Benkabbou A, Majbar MA et al. Oncological surgery during the COVID‐19 pandemic: The need for deep and lasting measures. The Oncologist 2020;25:e1424–e1425. - PMC - PubMed
1. Xu S, Li Y. Beware of the second wave of COVID‐19. Lancet 2020;395:1321–1322. - PMC - PubMed
1. De Filippo O, D'Ascenzo F, Angelini F et al. Reduced rate of hospital admissions for ACS during Covid‐19 outbreak in Northern Italy. N Engl J Med 2020. [Epub ahead of print]. - PMC - PubMed
1. Hollander JE, Carr BG. Virtually perfect? Telemedicine for Covid‐19. N Engl J Med 2020;382:1679–1681. - PubMed
1. Al‐Shamsi HO, Alhazzani W, Alhuraiji A et al. A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID‐19) pandemic: An international collaborative group. The Oncologist 2020. [Epub ahead of print]. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Evolution of Cancer Care in Response to the COVID-19 Pandemic

Affiliations

Evolution of Cancer Care in Response to the COVID-19 Pandemic

Authors

Affiliations

Abstract

Comment on

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical